Radiation Oncology Journal

The Korean Society for Radiation Oncology (대한방사선종양학회)
권호 표지

A Role of Trial Radiation Therapy in the Pineal Region Tumors

송과체부 종양에서 시험적 방사선치료의 역할

  • Kim, Yeon-Shil (Department of Radiation Oncology, Kangnam St. Mary's Hospital, The Catholic University of Korea) ;
  • Ryu, Mi-Ryung (Department of Radiation Oncology, Kangnam St. Mary's Hospital, The Catholic University of Korea) ;
  • Chung, Su-Mi (Department of Radiation Oncology, Kangnam St. Mary's Hospital, The Catholic University of Korea) ;
  • Kim, Moon-Chan (Department of Neurosurgery, Catholic Cancer Center, Kangnam St. Mary's Hospital, The Catholic University of Korea) ;
  • Yoon, Sei-Chul (Department of Radiation Oncology, Kangnam St. Mary's Hospital, The Catholic University of Korea)
  • 김연실 (가톨릭대학교 의과대학 치료방사선학교실) ;
  • 유미령 (가톨릭대학교 의과대학 치료방사선학교실) ;
  • 정수미 (가톨릭대학교 의과대학 치료방사선학교실) ;
  • 김문찬 (가톨릭대학교 의과대학 신경외과학교실, 가톨릭 암센터) ;
  • 윤세철 (가톨릭대학교 의과대학 치료방사선학교실)
  • Published : 2002.06.01
Download PDF
⟨ Previous Next ⟩

Abstract

Purpose : The aim of this retrospective study was to assess the treatment results of 30 patients with pineal region tumors who were underwent radiation therapy under the diagnosis by either CT or MRI. There was no histological verification. We analyzed the prognostic factors that have a significant effect on the overall survival (OS) and disease free survival (DFS) rates. Materials and Methods : A total 30 patients with pineal region tumors were treated between March 1983 and August 1995. After a trial radiation therapy of $20\~30\;Gy/2\~3$ weeks, the patients were evaluated for their clinical response and radiological response by either CT or MRI and the final treatment direction was then decided. According to their response to the trial radiation therapy and the involved site, radiation treatment was given in various fields i.e., local, ventricle, whole brain and craniospinal field. The radiation dose ranged from 40.8 to 59.4 Gy (Median 50.4 Gy). The median follow up was 36.5 months $(4\~172\;months)$. Results : An improvement or stability in the clinical symptoms was observed in 28 patients $(93.3\%)$ after the trial RT. Nineteen patients $(63.3\%)$ showed a partial or complete response by CT or MRI. The two-year and five-year survival rates of the patients were $66.7\%$ and $55.1\%$, respectively. No significant difference in the survival rates according to the degree of the radiological response was abserved after the trial RT. The results of univariate analysis showed that age, the primary site, the performance status $(KPS\geq70)$, the degree of response after completing RT and the RT field were significant prognostic factors affecting the survival and disease free survival rates (p<0.05). Conclusion : The clinical and histological characteristics of pineal region tumors are quite complex and diverse. Therefore, it is difficult to predict the histological diagnosis and the possibility of radiocurability only with the initial response to RT. We think that the development of less invasive histological diagnostic techniques and tailored treatment to the histological type of each tumor are needed.

목적 : 뇌중심부에 위치한 종양의 치료에 수술적 절제는 높은 치사율과 합병증을 동반한다. 조직학적 진단을 얻지못한 뇌중심부 종양의 치료로 $20\~30\;Gy$의 시험적 방사선치료를 시행할 수 있으며 방사선에 대한 반응 정도로 조직학적 유형을 예상하여 적절한 치료 방침을 정할 수 있다. 이 연구는 조직학적 진단 없이 영상적 진단 하에 방사선치료를 시행한 송과체부 종양환자 30명의 치료결과를 후향적으로 분석하여 방사선치료의 유용성 및 방사선치료로 치유 가능한 종양의 특성을 알아보고자 하였다. 대상 및 방법 : 1983년 3월부터 1995년 8월까지 강남성모병원 치료방사선과에서 송과체부 종양으로 조직학적 진단을 얻지 못하고 방사선치료를 시행한 30명의 환자를 대상으로 하였다. 환자들의 연령범위는 $7\~69$세(중앙값 16세)였으며 종양의 위치는 송과선(pineal gland) 18명$(60\%)$, 뇌하수체상부(suprasellar) 4명$(13.3\%)$, 송과선과 뇌하수체상부(pineal gland & suprasella) 2명$(6.7\%)$, 송과선와 주변 뇌실(pineal gland and paraventricle) 6명$(20\%)$이었다. $20\~30\;Gy/2\~3$주의 시험적 방사선치료를 시행한 후 CT 혹은 MRI를 추적 검사하여 방사선 반응성에 따라 최종 치료방침 및 방사선조사범위를 다시 결정하였다. 총방사선치료선량 범위는 $40.8\~59.4\;Gy$였으며(중앙값:50.4 Gy) 환자들의 중앙추적 기간은 36.5개월이었다($4\~172$개월). 결과 : 시험적 방사선치료 후 28명$(93.3\%)$의 환자에서 임상증상이 호전 혹은 안정되었고 영상학적 검사상 19명$(63.3\%)$에서 부분관해이상의 반응을 보였다. 전체환자의 2년 생존률과 5년 생존률은 각각 $66.7\%,\;55.1\%$였다. 시험적 방사선치료 후 임상 증상, 방사선 영상학적 반응정도에 따른 생존률의 차이는 없었다. 연령, 원발종양의 위치, 활동 수행정도$(KPS\geq70)$, 방사선치료 종료 후 최종 반응정도, 방사선조사야가 단변량분석에서 생존률과 무병생존률에 영향을 미치는 예후인자였다(p<0.05). 결론 : 시험적 방사선치료를 시행한 $63.3\%$의 환자에서 영상학적으로 종양의 반응이 관찰되었다. 그러나 뇌중심부 종양의 임상적 조직학적 양상은 매우 복잡 다양하여 초기 방사선 반응성만으로 조직학적 진단의 유추 및 완치여부를 예측하기는 어렵다. 향후에는 이와 같은 종양에서 1차적 시험적 방사선치료의 적용보다는 좀더 정확하고 비침습적인 조직학적 진단방법의 개발과 이에 따른 적절한 치료가 필요하다고 생각한다.

Keywords

References

  1. Levin VA, Leibel SA, Gutin PH. Neoplasm of central nervous system. In Devita VT Jr, Hellman S, Rosenberg SA, eds. Cancer : Principles and Practice of Oncology. 5th ed. Philadelphia PA : Lippincott Co, 1997:2064-2066
  2. DeGirolami U, Schmidek HH. Clinicopathological study of 53 tumor of the pineal region. J Neurosurg 1973;39:455-462 https://doi.org/10.3171/jns.1973.39.4.0455
  3. Chao CK, Lee ST, Lin FJ, Tang SG, Leung WM. A multivariate analysis of prognostic factors in management of pineal tumor. Int J Radiat Oncol Biol Phys 1993;27:1185-1191 https://doi.org/10.1016/0360-3016(93)90542-4
  4. Wara WM, Jenkin RD, Evans A, et al. Tumor of the pineal and suprasellar region : Children's Cancer Study Group Results, 1960~1975. Cancer 1979:43:698
  5. Donat JF, Okazaki H, Gomez MR, Reagan TJ, Baker HL Jr, Laws ER Jr. Pineal tumors : A 53 years experience. Arch Neurol 1978;35:736-740 https://doi.org/10.1001/archneur.1978.00500350040008
  6. Vaquero J, Ramiro J, Martez R, Bravo G. Neurosurgical experience with tumor of the pineal region at Clinica Puerta de Hierro. Acta Neurochir 1992;116(1):23-32 https://doi.org/10.1007/BF01541249
  7. Linggood RM, Chapman PH. Pineal tumor. J Neurooncol 1992;12:85-91
  8. Kang JK, Jean SS, Hong YK, Park CK, Son BC, Lee IW, Kim MC. Experience of pineal region tumor. Childs Nerv Syst 1998;14:63-68 https://doi.org/10.1007/s003810050177
  9. Oi S, Matsuzawa K, Choi JU, Kim DS, Kang KJ, Choi BK. Identical characteristics of the patient poptulations with pineal region tumors in Japan and in Korea and therapeutic modality. Childs Nerv Syst 1998;14:36-40 https://doi.org/10.1007/s003810050172
  10. Oi S. Recent advances and radical differences in therapeutic strategy to the pineal region tumor. Childs Nerv Syst 1998;14:33-35 https://doi.org/10.1007/s003810050171
  11. Leibel SA, Sheline GE. Radiation therapy for neoplasm of the brain. J Neurosurg 1987;66:1-22 https://doi.org/10.3171/jns.1987.66.1.0001
  12. Wolden SL, Wara WM, Larson DA, Prados MD, Edwards MS, Sneed PK. Radiation therapy for intracranial germ cell tumors. Int J radiat Oncol Biol Phys 1995;32:943 https://doi.org/10.1016/0360-3016(95)00067-9
  13. Sakai N, Yamada N, Andoh T, Hirata T, Shimizu K, Shinoda J. Primary intracranial germ cell tumor. Acta Oncologica 1988;27:43-50 https://doi.org/10.3109/02841868809090317
  14. Hermann HD, Winkler D, Westphal M. Treatment of tumors of the pineal region and posterior part of the 3rd ventricle. Acta Neurochir 1992;116:137-146 https://doi.org/10.1007/BF01540866
  15. Finlay J, Walker R, Balmaceda, et al. Chemotheapy without irradiation (XRT) for primary central nervous system (CNS) germ cell tumor (GCT) : a report of international study. Am Soc Clin Oncol 1992;11:A420
  16. Allen JC, DaRosso RC, Donahue B, Nirenberg A. A phase II trial of preirradiation carboplatin in newly diagnosed germinoma of central nervous system. Cancer 1994;74(3):940-944 https://doi.org/10.1002/1097-0142(19940801)74:3<940::AID-CNCR2820740323>3.0.CO;2-U
  17. Balmaceda C, Heller G, Rosenblum M, et al. Chemotherapy without irradiation - novel approach for newly diagnosed CNS germ cell tumor: results of international cooperative trial. The First International Central Nervous System Germ Cell Tumor Study. J Clin Oncol 1996;14(11):2908-15 https://doi.org/10.1200/JCO.1996.14.11.2908